NVO - Eli Lilly's tirzepatide cleared for diabetes treatment in China May, 21 2024 06:43 AM Novo Nordisk A/S 2024-05-21 06:43:02 ET Eli Lilly ( NYSE: LLY ) has secured China approval for its blockbuster drug tirzepatide for use in treating diabetes.... For further details see: Eli Lilly’s tirzepatide cleared for diabetes treatment in China